CSL LIMITED ORDINARY (CSL) Short Interest
CSL LIMITED ORDINARY (ASX:CSL) had 0.61% of shares reported as short positions as of 16 May 2026, representing 2,897,979 shares. CSL LIMITED ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
- Short interest
- 0.61%
- Reported positions
- 2,897,979
- Industry
- Pharmaceuticals, Biotechnology & Life Sciences
- As of
- 16 May 2026
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
CSL
Csl
CSL Limited is a global biotechnology company specializing in the development, manufacturing, and marketing of life-saving biotherapies, vaccines, and diagnostic products. Its core business revolves around plasma-derived therapies, which treat a range of serious medical conditions, and recombinant technologies. CSL holds a leading market position in several therapeutic areas, leveraging its extens...